We confirmed that SCD retains significant enzymatic activity even in very hypoxic conditions—a result that should persuade SCD inhibitor therapeutics in other strong tumors. As well as delaying tumor advancement, the inhibitor experienced an unexpected useful effect on tumor vasculature, secondary to its impact on tumor cells. GBM is really https://wernerg555wit9.activablog.com/profile